Average Insider

Where insiders trade, we follow

Insider Buy/Sell Ratio for March 2026

Extreme outlier transactions (>3ฯƒ) are excluded.Show All Data
Ratio0.2:1
Daily Buy & Sell Volume

By Sector

By Industry

Alkermes plc. (ALKS)

Nichols Christian Todd โ€” SVP, Chief Commercial Officer
Mar 2, 2026
Sale
Shares
6,000
Price
$30.00
Total Value
$180.00K
Shares Held After
109,769
% of Holdings
5.2%

Adaptive Biotechnologies Corp (ADPT)

ROBINS HARLAN S โ€” Chief Scientific Officer
Mar 2, 2026
Sale
Shares
10,000
Price
$15.72
Total Value
$157.20K
Shares Held After
1,169,524
% of Holdings
0.8%
Mar 2, 2026
Sale
Shares
22,500
Price
$14.35
Total Value
$322.84K
Shares Held After
998,680
% of Holdings
2.2%

Apogee Therapeutics, Inc. (APGE)

Henderson Jane โ€” Chief Financial Officer
Mar 2, 2026
Sale
Shares
406
Price
$71.66
Total Value
$29.09K
Shares Held After
181,371
% of Holdings
0.2%

Apogee Therapeutics, Inc. (APGE)

Henderson Jane โ€” Chief Financial Officer
Mar 2, 2026
Sale
Shares
994
Price
$70.45
Total Value
$70.03K
Shares Held After
181,777
% of Holdings
0.5%

Apogee Therapeutics, Inc. (APGE)

Henderson Jane โ€” Chief Financial Officer
Mar 2, 2026
Sale
Shares
300
Price
$69.43
Total Value
$20.83K
Shares Held After
182,771
% of Holdings
0.2%

Motorsport Games Inc. (MSGM)

ZOI MIKE โ€” 10% Owner
Mar 2, 2026
Sale
Shares
6,500
Price
$3.74
Total Value
$24.31K
Shares Held After
1,388,474
% of Holdings
0.5%

Apogee Therapeutics, Inc. (APGE)

Henderson Jane โ€” Chief Financial Officer
Mar 2, 2026
Sale
Shares
300
Price
$68.27
Total Value
$20.48K
Shares Held After
183,071
% of Holdings
0.2%
Shares
238,991
Price
$12.03
Total Value
$2.88M
Shares Held After
3,456,531
% of Holdings
6.5%
Shares
1,440
Price
$25.08
Total Value
$36.12K
Shares Held After
349,907
% of Holdings
0.4%
Shares
700
Price
$22.03
Total Value
$15.42K
Shares Held After
745,119
% of Holdings
0.1%
Mar 2, 2026
Sale
Shares
24,875
Price
$30.07
Total Value
$747.91K
Shares Held After
13,450
% of Holdings
64.9%

Meta Platforms, Inc. (META)

Olivan Javier โ€” Chief Operating Officer
Mar 2, 2026
Sale
Shares
408
Price
$637.21
Total Value
$259.98K
Shares Held After
89,269
% of Holdings
0.5%

Meta Platforms, Inc. (META)

Olivan Javier โ€” Chief Operating Officer
Mar 2, 2026
Sale
Shares
82
Price
$637.21
Total Value
$52.25K
Shares Held After
8,376
% of Holdings
1.0%

Meta Platforms, Inc. (META)

Olivan Javier โ€” Chief Operating Officer
Mar 2, 2026
Sale
Shares
57
Price
$637.21
Total Value
$36.32K
Shares Held After
2,828
% of Holdings
2.0%

Meta Platforms, Inc. (META)

Olivan Javier โ€” Chief Operating Officer
Mar 2, 2026
Sale
Shares
82
Price
$637.21
Total Value
$52.25K
Shares Held After
8,376
% of Holdings
1.0%

Meta Platforms, Inc. (META)

Olivan Javier โ€” Chief Operating Officer
Mar 2, 2026
Sale
Shares
926
Price
$637.21
Total Value
$590.06K
Shares Held After
16,113
% of Holdings
5.4%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Tanguler Tolga โ€” EVP, Chief Commercial Officer
Mar 2, 2026
Sale
Shares
37
Price
$332.64
Total Value
$12.31K
Shares Held After
36,606
% of Holdings
0.1%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Tanguler Tolga โ€” EVP, Chief Commercial Officer
Mar 2, 2026
Sale
Shares
94
Price
$331.93
Total Value
$31.20K
Shares Held After
36,643
% of Holdings
0.3%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Tanguler Tolga โ€” EVP, Chief Commercial Officer
Mar 2, 2026
Sale
Shares
81
Price
$330.85
Total Value
$26.80K
Shares Held After
36,737
% of Holdings
0.2%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Tanguler Tolga โ€” EVP, Chief Commercial Officer
Mar 2, 2026
Sale
Shares
170
Price
$329.71
Total Value
$56.05K
Shares Held After
36,818
% of Holdings
0.5%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Tanguler Tolga โ€” EVP, Chief Commercial Officer
Mar 2, 2026
Sale
Shares
100
Price
$328.71
Total Value
$32.87K
Shares Held After
36,988
% of Holdings
0.3%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Tanguler Tolga โ€” EVP, Chief Commercial Officer
Mar 2, 2026
Sale
Shares
329
Price
$327.67
Total Value
$107.80K
Shares Held After
37,088
% of Holdings
0.9%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Tanguler Tolga โ€” EVP, Chief Commercial Officer
Mar 2, 2026
Sale
Shares
392
Price
$326.81
Total Value
$128.11K
Shares Held After
37,417
% of Holdings
1.0%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Tanguler Tolga โ€” EVP, Chief Commercial Officer
Mar 2, 2026
Sale
Shares
258
Price
$325.63
Total Value
$84.01K
Shares Held After
37,809
% of Holdings
0.7%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Tanguler Tolga โ€” EVP, Chief Commercial Officer
Mar 2, 2026
Sale
Shares
90
Price
$324.65
Total Value
$29.22K
Shares Held After
38,067
% of Holdings
0.2%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Tanguler Tolga โ€” EVP, Chief Commercial Officer
Mar 2, 2026
Sale
Shares
47
Price
$323.62
Total Value
$15.21K
Shares Held After
38,157
% of Holdings
0.1%

US ENERGY CORP (USEG)

Batchelor Joshua Lane โ€” 10% Owner
Mar 2, 2026
Sale
Shares
40,000
Price
$1.25
Total Value
$50.04K
Shares Held After
322,543
% of Holdings
11.0%

US ENERGY CORP (USEG)

Batchelor Joshua Lane โ€” 10% Owner
Mar 2, 2026
Sale
Shares
26,930
Price
$1.25
Total Value
$33.69K
Shares Held After
218,445
% of Holdings
11.0%

US ENERGY CORP (USEG)

Batchelor Joshua Lane โ€” 10% Owner
Mar 2, 2026
Sale
Shares
357,500
Price
$1.25
Total Value
$447.27K
Shares Held After
2,900,642
% of Holdings
11.0%

US ENERGY CORP (USEG)

Batchelor Joshua Lane โ€” 10% Owner
Mar 2, 2026
Sale
Shares
10,400
Price
$1.25
Total Value
$13.01K
Shares Held After
84,663
% of Holdings
10.9%
Mar 2, 2026
Sale
Shares
160
Price
$332.64
Total Value
$53.22K
Shares Held After
98,628
% of Holdings
0.2%
Mar 2, 2026
Sale
Shares
399
Price
$331.93
Total Value
$132.44K
Shares Held After
98,788
% of Holdings
0.4%
Mar 2, 2026
Sale
Shares
346
Price
$330.85
Total Value
$114.47K
Shares Held After
99,187
% of Holdings
0.3%
Mar 2, 2026
Sale
Shares
722
Price
$329.71
Total Value
$238.05K
Shares Held After
99,533
% of Holdings
0.7%
Mar 2, 2026
Sale
Shares
424
Price
$328.71
Total Value
$139.37K
Shares Held After
100,255
% of Holdings
0.4%
Mar 2, 2026
Sale
Shares
1,399
Price
$327.67
Total Value
$458.41K
Shares Held After
100,679
% of Holdings
1.4%
Mar 2, 2026
Sale
Shares
1,669
Price
$326.81
Total Value
$545.45K
Shares Held After
102,078
% of Holdings
1.6%
Mar 2, 2026
Sale
Shares
1,098
Price
$325.63
Total Value
$357.54K
Shares Held After
103,747
% of Holdings
1.0%
Mar 2, 2026
Sale
Shares
382
Price
$324.65
Total Value
$124.02K
Shares Held After
104,845
% of Holdings
0.4%

ALKAMI TECHNOLOGY, INC. (ALKT)

Sachdeva Prerna โ€” Chief Accounting Officer
Mar 2, 2026
Sale
Shares
1,352
Price
$16.90
Total Value
$22.85K
Shares Held After
63,608
% of Holdings
2.1%
Mar 2, 2026
Sale
Shares
200
Price
$323.62
Total Value
$64.72K
Shares Held After
105,227
% of Holdings
0.2%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Fitzgerald Kevin Joseph โ€” CSO & EVP, Head of Research
Mar 2, 2026
Sale
Shares
37
Price
$332.64
Total Value
$12.31K
Shares Held After
23,512
% of Holdings
0.2%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Fitzgerald Kevin Joseph โ€” CSO & EVP, Head of Research
Mar 2, 2026
Sale
Shares
94
Price
$331.93
Total Value
$31.20K
Shares Held After
23,549
% of Holdings
0.4%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Fitzgerald Kevin Joseph โ€” CSO & EVP, Head of Research
Mar 2, 2026
Sale
Shares
81
Price
$330.85
Total Value
$26.80K
Shares Held After
23,643
% of Holdings
0.3%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Fitzgerald Kevin Joseph โ€” CSO & EVP, Head of Research
Mar 2, 2026
Sale
Shares
170
Price
$329.71
Total Value
$56.05K
Shares Held After
23,724
% of Holdings
0.7%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Fitzgerald Kevin Joseph โ€” CSO & EVP, Head of Research
Mar 2, 2026
Sale
Shares
100
Price
$328.71
Total Value
$32.87K
Shares Held After
23,894
% of Holdings
0.4%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Fitzgerald Kevin Joseph โ€” CSO & EVP, Head of Research
Mar 2, 2026
Sale
Shares
329
Price
$327.67
Total Value
$107.80K
Shares Held After
23,994
% of Holdings
1.4%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Fitzgerald Kevin Joseph โ€” CSO & EVP, Head of Research
Mar 2, 2026
Sale
Shares
392
Price
$326.81
Total Value
$128.11K
Shares Held After
24,323
% of Holdings
1.6%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Fitzgerald Kevin Joseph โ€” CSO & EVP, Head of Research
Mar 2, 2026
Sale
Shares
258
Price
$325.63
Total Value
$84.01K
Shares Held After
24,715
% of Holdings
1.0%
Version: v26.3.33